Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study

BACKGROUND: The effectiveness of mRNA COVID-19 vaccines and the optimal timing of vaccine administration in allogeneic hematopoietic stem cell transplantation (Allo-HSCT) recipients remains inadequately investigated. We examine the effectiveness and safety of mRNA COVID-19 vaccines in allo-HSCT reci...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikubo, Masashi, Shimomura, Yoshimitsu, Maruoka, Hayato, Nasu, Seiko, Nishioka, Tomomi, Sakizono, Kenji, Mitsuyuki, Satoshi, Kubo, Tomoyo, Okada, Naoki, Nakagawa, Daishi, Kamijo, Kimimori, Imoto, Hiroharu, Yamamoto, Ryusuke, Nagai, Yuya, Hiramoto, Nobuhiro, Yoshioka, Satoshi, Yonetani, Noboru, Matsushita, Akiko, Miyakoshi, Chisato, Doi, Asako, Ishikawa, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699714/
https://www.ncbi.nlm.nih.gov/pubmed/36442827
http://dx.doi.org/10.1016/j.jiac.2022.11.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699714/
https://www.ncbi.nlm.nih.gov/pubmed/36442827
http://dx.doi.org/10.1016/j.jiac.2022.11.010

Ejemplares similares